MOLECULAR NEUROBIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-09-28 12149696m01暂无昵称

这个期刊是不是不限制文字和图片数量呀？找了半天没找到。

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-06-14 1239c479m01(暂无昵称)

偏重的研究方向：神经科学;神经分子
经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家

3 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-07-21 ms5000001753251891

偏重的研究方向：神经毒理学
经验分享：请问大家一审under review阶段有多久啊

35 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

投了3次了

253 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-08-30 ms3000好运气

请问一审大概要多少天啊？

72 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-05-10 ms7000001703520168

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：眼科学
经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了

47 0

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-03-12 1253339am59(暂无昵称)

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：脑卒中
经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-03-04 jk1403928214_10139251

您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？

37 0

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

我应该使用什么样的事后检验方法？

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2090834, encodeId=783e2090834c6, content=这个期刊是不是不限制文字和图片数量呀？找了半天没找到。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/07/11/dc9024541ba5df7d6f99988a72a9c31d.jpg, createdBy=dfe22242653, createdName=12149696m01暂无昵称, createdTime=Wed Sep 28 16:11:57 CST 2022, time=2022-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226491, encodeId=4289122649175, content=偏重的研究方向：神经科学;神经分子 经验分享：大佬/大神们，请问这个reviewer assignment pending要多久啊？为什么我没有编辑分配阶段啊？有一样情况的同道吗？帮帮忙🥺谢谢大家, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q3auHgzwzM5EEW8g6ksdIyqaibkJkia1A1I61iaGDkPIMnc4YcyNzkKPrOWmp4FYica2UhOSpNBNqnR6ibqWPENZKjg/132, createdBy=5fc32422530, createdName=1239c479m01(暂无昵称), createdTime=Tue Jun 14 22:21:21 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233803, encodeId=9adc1233803fd, content=偏重的研究方向：神经毒理学 经验分享：请问大家一审under review阶段有多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d0b6143982, createdName=ms5000001753251891, createdTime=Thu Jul 21 11:47:01 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578777, encodeId=3dc65e877745, content=投了3次了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012909, encodeId=11921012909d5, content=请问一审大概要多少天啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4bf5545145, createdName=ms3000好运气, createdTime=Mon Aug 30 16:13:46 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218462, encodeId=daa112184625d, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：眼科学 经验分享：投的review，一审非常慢，长达6个月，但是回来的结果是小修，一周修回后几天就接受了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b128154149, createdName=ms7000001703520168, createdTime=Tue May 10 15:18:47 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201878, encodeId=adf512018e8fa, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：脑卒中 经验分享：二审1个月了，还在under review，日期也没变过，正常吗？我看往期评论里说二审很快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e65e2547063, createdName=1253339am59(暂无昵称), createdTime=Sat Mar 12 01:36:02 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199488, encodeId=86cb1199488cd, content=您好，请问下这个杂志的figure可以上传pdf吗，还是非的word啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7cf2449489, createdName=jk1403928214_10139251, createdTime=Fri Mar 04 21:44:52 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095517, encodeId=64c5109551ecc, content=我应该使用什么样的事后检验方法？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095518, encodeId=5ccb10955188d, content=p<0.05够么？什么时候要求p<0.01?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 Gym璨烨

p<0.05够么？什么时候要求p<0.01?

53 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务